Endocrine Abstracts

Introduction: Flash glucose monitoring has been widely used for people with T1DM over the last 10 years. In March 2022 NICE guidelines recommended extending use to people with T2DM on insulin, previously use was limited to people on dialysis and those self-funding.Aim: To examine the use and outcomes of flash glucose monitoring in people with T2DM.Methods: People with T2DM locally who have used flash glucose monitoring for more tha...

Background: Severe hypoglycemia, marked by blood glucose levels below 3 mmol/l (level 2) or necessitating third-party assistance (level 3), poses a significant risk leading to unplanned hospital admissions in individuals with diabetes. However, there is a paucity of information on admitted patients’ characteristics, management, and outcomes.Objective: To explore the characteristics of the population, precipitating factors and outcomes of people admi...